# FDA Guidance on Informed Consent and Recruitment

## Key Regulatory Requirements (21 CFR Part 50, 56)

### Basic Elements of Informed Consent
Per 21 CFR ยง50.25(a), informed consent must include:

1. **Statement of Purpose**
   - That the study involves research
   - Explanation of purposes, procedures, and duration
   - Identification of experimental procedures

2. **Risks and Discomforts**
   - Reasonably foreseeable risks
   - Discomforts that may be encountered

3. **Benefits**
   - Benefits to the subject (if any)
   - Benefits to others that may reasonably be expected

4. **Alternative Procedures**
   - Disclosure of appropriate alternative procedures

5. **Confidentiality Statement**
   - Extent of confidentiality maintained
   - FDA may inspect records

6. **Compensation and Treatment**
   - Whether compensation is available
   - Whether medical treatments are available for injury

7. **Contacts**
   - For questions about research: researcher contact
   - For questions about rights: IRB contact

8. **Voluntary Participation**
   - Participation is voluntary
   - Refusal to participate involves no penalty
   - May discontinue at any time without penalty

## Recruitment Advertising Requirements

### FDA Information Sheets Guidance

Recruitment materials must not:
- **Promise benefits** beyond what is outlined in the protocol
- **Use coercion** or undue influence
- **Emphasize payment** as the primary benefit
- **Claim superiority** of investigational products

### Acceptable Language

| Avoid | Use Instead |
|-------|-------------|
| "Free treatment" | "Study-related care provided at no cost" |
| "Cure your disease" | "Help advance research" |
| "New wonder drug" | "Investigational medication" |
| "Limited spots available" | "Enrollment is ongoing" |
| "Sufferers of..." | "People with..." |

### Payment Disclosure

- Payment should not be the **emphasis** of recruitment materials
- Amount may be stated if reasonable
- Payment for time/inconvenience is acceptable
- Payment contingent on completion must be disclosed

## IRB Review of Recruitment Materials

Recruitment materials are considered part of the informed consent process and must be reviewed and approved by the IRB before use.

### Materials Subject to Review:
- Print advertisements (newspapers, flyers)
- Audio/video advertisements
- Social media posts
- Website content
- Recruitment letters
- Scripts for telephone recruitment

### IRB Approval Statement:
Include IRB approval number and contact information for questions about participant rights.

## References

- FDA 21 CFR Part 50: Protection of Human Subjects
- FDA 21 CFR Part 56: Institutional Review Boards
- FDA Guidance: Informed Consent Information Sheet
- FDA Guidance: Payment and Reimbursement to Research Subjects
